Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
2.7.11.15
Transferases;
Transferring phosphorus-containing groups;
Protein-serine/threonine kinases;
β-adrenergic-receptor kinase
PDB | Resolution (Å) | PDB name |
---|---|---|
1BAK | SIGNAL TRANSDUCTION PLECKSTRIN HOMOLOGY DOMAIN OF G-PROTEIN COUPLED RECEPTOR KINASE 2 (BETA-ADRENERGIC RECEPTOR KINASE 1), C-TERMINAL EXTENDED, NMR, 20 STRUCTURES | |
3CIK | 2.75 | Human GRK2 in Complex with Gbetagamma subunits |
3KRW | 2.9 | Human GRK2 in complex with Gbetgamma subunits and balanol (soak) |
3KRX | 3.1 | Human GRK2 in complex with Gbetgamma subunits and balanol (co-crystal) |
3V5W | 2.07 | Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine |
4MK0 | 2.4 | Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative |
4PNK | 2.56 | G protein-coupled receptor kinase 2 in complex with GSK180736A |
5HE1 | 3.15 | Human GRK2 in complex with Gbetagamma subunits and CCG224062 |
5UKK | 2.6 | Human GRK2 in complex with human G-beta-gamma subunits and CCG211998 (14ak) |
5UKL | 2.15 | Human GRK2 in complex with Gbetagamma subunits and CCG222886 (14bd) |
5UUU | 2.7 | Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure |
5UVC | 2.65 | Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure |
5WG3 | 2.896 | Human GRK2 in complex with Gbetagamma subunits and CCG258748 |
5WG4 | 2.31 | Human GRK2 in complex with Gbetagamma subunits and CCG257284 |
5WG5 | 3.1 | Human GRK2 in complex with Gbetagamma subunits and CCG224061 |
6C2Y | 2.74 | Human GRK2 in complex with Gbetagamma subunits and CCG257142 |
6U7C | 2.44 | Human GRK2 in complex with Gbetagamma subunits and CCG258747 |
7K7L | 2.539 | Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure |
7K7Z | 2.60609 | Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure |
7PWD | 2.6 | Structure of an inhibited GRK2-G-beta and G-gamma complex |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0007213 | G protein-coupled acetylcholine receptor signaling pathway |
Biological Process | GO:0007186 | G protein-coupled receptor signaling pathway |
Biological Process | GO:0060048 | cardiac muscle contraction |
Biological Process | GO:0002029 | desensitization of G protein-coupled receptor signaling pathway |
Biological Process | GO:0007507 | heart development |
Biological Process | GO:1901081 | negative regulation of relaxation of smooth muscle |
Biological Process | GO:0045988 | negative regulation of striated muscle contraction |
Biological Process | GO:0003108 | negative regulation of the force of heart contraction by chemical signal |
Biological Process | GO:0018105 | peptidyl-serine phosphorylation |
Biological Process | GO:0018107 | peptidyl-threonine phosphorylation |
Biological Process | GO:0033605 | positive regulation of catecholamine secretion |
Biological Process | GO:0006468 | protein phosphorylation |
Biological Process | GO:0031623 | receptor internalization |
Biological Process | GO:0002026 | regulation of the force of heart contraction |
Biological Process | GO:0007217 | tachykinin receptor signaling pathway |
Biological Process | GO:0046718 | viral entry into host cell |
Biological Process | GO:0019079 | viral genome replication |
Molecular Function | GO:0005524 | ATP binding |
Molecular Function | GO:0031755 | Edg-2 lysophosphatidic acid receptor binding |
Molecular Function | GO:0001664 | G protein-coupled receptor binding |
Molecular Function | GO:0004703 | G protein-coupled receptor kinase activity |
Molecular Function | GO:0031694 | alpha-2A adrenergic receptor binding |
Molecular Function | GO:0047696 | beta-adrenergic receptor kinase activity |
Molecular Function | GO:0004672 | protein kinase activity |
Cellular Component | GO:0005929 | cilium |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0016020 | membrane |
Cellular Component | GO:0005886 | plasma membrane |
Cellular Component | GO:0098794 | postsynapse |
Cellular Component | GO:0098793 | presynapse |
InterPro | InterPro name |
---|---|
IPR000239 | GPCR kinase |
IPR000719 | Protein kinase domain |
IPR000961 | AGC-kinase, C-terminal |
IPR001849 | Pleckstrin homology domain |
IPR008271 | Serine/threonine-protein kinase, active site |
IPR011009 | Protein kinase-like domain superfamily |
IPR011993 | PH-like domain superfamily |
IPR016137 | RGS domain |
IPR017441 | Protein kinase, ATP binding site |
IPR036305 | RGS domain superfamily |
IPR044926 | RGS, subdomain 2 |
Pfam | Pfam name |
---|---|
PF00069 | Protein kinase domain |
PF00169 | PH domain |
PF00615 | Regulator of G protein signaling domain |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-111933 | Calmodulin induced events | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-416476 | G alpha (q) signalling events | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-418555 | G alpha (s) signalling events | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-5635838 | Activation of SMO | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | Leaf | R-HSA-5653656 | Vesicle-mediated transport |
Location | ECO term | Pubmed |
---|---|---|
Cell membrane | ECO:0000250 | |
Cytoplasm | ECO:0000250 | |
Postsynapse | ECO:0000250 | |
Presynapse | ECO:0000250 |